Artal Group S.A. Cytokinetics Inc Transaction History

Artal Group S.A.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $582,121 - $912,833	-12,163 Reduced 2.4%	494,421 $26.8 Million
Q1 2024 May 13, 2024	SELL	$63.75 - $108.06 $45.1 Million - $76.5 Million	-707,700 Reduced 58.28%	506,584 $35.5 Million
Q4 2023 Feb 09, 2024	SELL	$26.88 - $83.49 $8.19 Million - $25.4 Million	-304,547 Reduced 20.05%	1,214,284 $101 Million
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $3.03 Million - $3.76 Million	102,800 Added 7.26%	1,518,831 $44.7 Million
Q2 2023 Aug 11, 2023	BUY	$32.62 - $40.75 $1.6 Million - $2 Million	49,008 Added 3.59%	1,416,031 $46.2 Million
Q1 2023 May 12, 2023	BUY	$33.36 - $45.71 $12.2 Million - $16.8 Million	367,023 Added 36.7%	1,367,023 $48.1 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $10.6 Million - $15 Million	-275,000 Reduced 21.57%	1,000,000 $48.5 Million
Q2 2022 Aug 11, 2022	BUY	$33.93 - $48.92 $9.33 Million - $13.5 Million	275,000 Added 27.5%	1,275,000 $50.1 Million
Q4 2021 Feb 11, 2022	SELL	$34.35 - $46.38 $10.3 Million - $13.9 Million	-300,000 Reduced 23.08%	1,000,000 $45.6 Million
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $14.8 Million - $28.6 Million	800,000 Added 160.0%	1,300,000 $46.5 Million
Q2 2021 Aug 13, 2021	BUY	$19.79 - $26.99 $9.9 Million - $13.5 Million	500,000 New	500,000 $9.9 Million
Q1 2021 May 14, 2021	SELL	$18.57 - $25.68 $9.29 Million - $12.8 Million	-500,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$15.26 - $28.61 $7.63 Million - $14.3 Million	500,000 New	500,000 $10.4 Million

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.